JPRN-UMIN000007725招募中未知
Feasibility study of adjuvant nab-paclitaxel in breast cancer - FANAP-BC Study
Graduate school of medicine,Chiba University0 个研究点目标入组 55 人开始时间: 2012年4月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 55
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)Serious drug hypersensitivity 2)Other any cancer 3)Other severe complications 4)Symptomatic brain metastasis 5)Severe mental disorders 6)Active bleeding of digestive tract 7)Serious myeloablation,renal insufficciency,liver failure 8)Massive hydrothorax or ascites 9)Diarrhea 10)Active infection 11)Allergy of the Nab-paclitaxel,paclitaxel or albumin 12)Pregnant 13)Serious Docetaxel and Polysorbate-80 hypersensitivity 14)Not suitable for participating in the study for any other reason
研究者
相似试验
已完成
2 期
The Feasibility Study of Adjuvant nab-paclitaxel+Carboplatin in Patients with Resected Stage IB-IIIA Non-Small-Cell Lung Cancenon-small cell lung cancerJPRN-UMIN000011315Hiroshima University40
已完成
2 期
A study of neoadjuvant nab-paclitaxel followed by FEC for luminal B-like (HER2-negative) and triple-negative breast canceruminal B-like (HER2-negative) or triple-negative operable breast cancerJPRN-UMIN000017675Kyushu Breast Cancer Study Group (KBC-SG)94
已完成
2 期
A feasibility study of Nab-Paclitaxel followed by Anthracycline-based regimen as adjuvant chemotherapy for breast cancer.(SBCCSG-21)Primary breast cancerJPRN-UMIN000006084Saitama Breast Cancer Clinical Study Group(SBCCSG)30
已完成
2 期
Pilot study of low-dose Nab-paclitaxel as adjuvant chemotherapy in patients with breast cancerBreast CancerJPRN-UMIN000012047Kitasato University Kitasato Institute Hospital20
已完成
不适用
A phase II study of nab-paclitaxel for pretreated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000012972Kanagawa Cancer Center30